Xcision Medical Systems

It’s about time to give early-stage breast cancer patients—no matter where they live—a new option for short, comfortable treatment. GammaPod is a radiotherapy treatment that women need—and deserve.

Find out about GammaPod as a treatment option: https://tinyurl.com/bdz6wypw

Xcision is committed to bringing women with early-stage breast cancer a radiotherapy treatment that is needed—and deserved. Improve patients’ quality of life by lowering toxicity, maintaining the overall appearance of the breast and significantly decreasing the number of treatments.

GammaPod is:
🎀 Patient friendly—a comfortable, gentle experience
🎀 Protective—non-invasive, non-surgical with a fast & painless recovery time
🎀 Proven—cleared by FDA

Find out more here: https://xcision.com/.

GammaPod is purpose-built radiotherapy for women with early-stage breast cancer. In a short time, patients are delivered a precise treatment with ease, comfort and convenience. Isn’t it about time you and your patients had another choice? Hear from a GammaPod patient to learn more: https://lnkd.in/ekc-ZTgY

Xcision supports breast cancer awareness in October. With GammaPod, a dedicated, distinctive radiotherapy system with less toxicity, superior dose distribution and improved patient throughput, we have prioritized a better quality of life for patients with early-stage breast cancer. And with a patient-friendly treatment schedule, women spend significantly less time at the oncology center - and on the treatment table.

Find out more about GammaPod: https://xcision.com/

breastcancercare

As health care systems demand greater value, providers are looking for ways to maximize care and minimize cost. The GammaPod system provides highly conformal, non-invasive breast cancer treatments that can shorten the course of radiotherapy, while limiting doses to the whole breast, heart and lungs. Find out why GammaPod can be a smart choice for providers: https://xcision.com/gammapod/why-gammapod/

What Sets GammaPod Apart? Cedric Yu, GammaPod inventor and founder of Xcision Medical Systems, discusses no pain, no anesthesia and no scars. Read an insightful article about how an idea to create a more convenient radiotherapy technology came about—and how GammaPod is now available to women with early-stage breast cancer.

Read here: https://xcision.com/developing-gammapod/

What can patients expect during a GammaPod treatment for early-stage breast cancer? First, they can get back to their life faster! GammaPod treatments are extremely gentle, virtually painless, and relatively short compared to most cancer treatments. Check out our new patient resource guide: https://tinyurl.com/y35fmxhf

Xcision, along with an expert presenter, Asal Rahimi, MD, Associate Professor and Chief of Breast Irradiation, UT Southwestern Medical Center, discusses GammaPod and SPBI, initial clinical experiences, the technology and workflow, as well as several case studies with clinical outcomes using the GammaPod in its latest on demand webinar series.

View here to learn more: https://lnkd.in/eCddnFAe

This June, National Cancer Survivors Month, please join Xcision as we recognize the more than 18 million cancer survivors in the United States and the work being done to improve the lives of all survivors and their caregivers.

Among today’s survivors, one of the most common cancer types represented include female breast cancer, where there are 4.1 million survivors.

👉 Watch here: https://lnkd.in/e4gcWn69

In this webinar, Dr. Elizabeth Nichols discusses:
• The background and rationale for partial breast irradiation
• Initial experiences on clinical use with GammaPod
• The technology and the workflow of the system
• Case studies and clinical outcomes

👉 Don't miss this insightful article: https://lnkd.in/eH2GjjB9

Cedric Yu, GammaPod inventor and founder of Xcision Medical Systems, LLC, talks about how an idea to create a more convenient radiotherapy technology came about—and how the GammaPod is now available to women with breast cancer.

“If there is one message that I want to give, it would be my gratitude to all the patients who willingly participated in the trials that our clinical collaborators are conducting. They are the true pioneers working toward the goal of improving care for other women in the world.” - Cedric Yu

As part of the bipartisan bill to modernize radiation oncology reimbursement introduced in the U.S. Congress, The Radiation Oncology Case Rate (ROCR) Value-Based Payment Program Act would improve access, enhance quality and support shorter treatments for certain cancers. This would allow patients to return to work faster and spend more time with loved ones while undergoing the treatment process. Read full statement here: https://lnkd.in/e3qCH2t6

Xcision Medical Systems fully supports policymakers and radiation oncology stakeholders that are part of this pioneering program to enhance the landscape of cancer treatment across the United States.

Michelle Crawley, President of Xcision, commented on how the ROCR’s ability to maximize care and minimize costs for providers and patients fits perfectly with Xcision’s GammaPod radiotherapy system, noting that:

👍GammaPod provides highly conformal, non-invasive early-stage breast cancer treatments that can shorten the course of radiotherapy, while limiting doses to the whole breast, heart and lungs.

👍GammaPod addresses the growing global demand for high-value radiation therapy, more efficient and cost-effective breast cancer care by helping patients with early-stage breast cancer get back to their lives faster.

To learn more about how GammaPod is a smart choice for cancer care providers, visit https://xcision.com/.

hashtag